Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02324062 · ClinicalTrials.gov registry record
Cancer Genetics Hereditary Cancer Panel Testing
A clinical trial, sponsored by University of Southern California.
- Completed
- Registry status
- 1,511
- Enrollment target
NCT02324062 is a clinical trial that has completed, run by University of Southern California. The registered enrollment target is 1,511 participants.
The verdict
NCT02324062 has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- 1,511 participants
- Enrollment target
Study Summary
This study is about understanding the use of a genetic test (Myriad Genetics myRisk panel) that analyzes 25 genes related to different hereditary cancer conditions. The investigators hope to learn more about how this type of genetic test is used clinically. The investigators also hope to understand more about the experience of individuals and families who undergoing this test of genetic testing.
Interventions
- OTHER Questionnaires
- OTHER Blood Draw and Baseline Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,511 participants |
| Start Date | 2014-06-12 |
| Est. Completion | 2020-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02324062
The ClinicalTrials.gov registry entry for NCT02324062 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,511 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Questionnaires is the first listed.
NCT02324062 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02324062 about?
NCT02324062 is a clinical study titled "Cancer Genetics Hereditary Cancer Panel Testing". This study is about understanding the use of a genetic test (Myriad Genetics myRisk panel) that analyzes 25 genes related to different hereditary cancer conditions. The investigators hope to learn more about how this type of genetic test is used clinically. The investigators also hope to understand ...
What is the current status of trial NCT02324062?
This trial is currently completed. The enrollment target is 1,511 participants. The study started on 2014-06-12. Estimated completion is 2020-08-31.
What interventions are being tested in trial NCT02324062?
The interventions under investigation include: Questionnaires (OTHER), Blood Draw and Baseline Questionnaire (OTHER).
Who is sponsoring clinical trial NCT02324062?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.